The association of a distinct plasma proteomic profile with the cervical high-grade squamous intraepithelial lesion of Uyghur women: A 2D liquid-phase chromatography/mass spectrometry study

Biomarkers

Volumn 17, Issue 4, 2012, Pages 352-361

  Guo, Xia ^a   Abliz, Guzalnur ^a   Reyimu, Halidan ^a   Zhao, Feng ^a   Kadeer, Nafeisha ^a   Matsidik, Rukeya ^a   Wu, Guizhen ^a   Abudula, Abulizi ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

2D liquid phase chromatography; Biomarkers; High grade squamous intraepithelial lesion; Low abundant plasma proteome; Uyghur women

Indexed keywords

APOLIPOPROTEIN A1; MAMMALIAN TARGET OF RAPAMYCIN; PLASMA PROTEIN;

ARTICLE; DATA ANALYSIS SOFTWARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETER; PROTEIN ANALYSIS; PROTEIN SECRETION; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA;

ADULT; APOLIPOPROTEIN A-I; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PROTEINS; BRACHIAL PLEXUS NEURITIS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMATOGRAPHY, REVERSE-PHASE; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; PLACENTAL LACTOGEN; PROTEOMICS; TANDEM MASS SPECTROMETRY; TOR SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 84861628793     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.673133     Document Type: Article

References (42)

1. Azim H, Azim HA Jr, Escudier B. (2010). Targeting mTOR in cancer: renal cell is just a beginning. Target Oncol 5:269-280.
2. Cohen J. (2005). Public health. High hopes and dilemmas for a cervical cancer vaccine. Science 308:618-621.
3. Correa P. (1988). A human model of gastric carcinogenesis. Cancer Res 48:3554-3560.
4. Cho WC, Cheng CH. (2007). Oncoproteomics: current trends and future perspectives. Expert Rev Proteomics 4:401-410.
5. Chang SJ, Hou MF, Tsai SM, Wu SH, Hou LA, Ma H, Shann TY, Wu SH, Tsai LY. (2007). The association between lipid profiles and breast cancer among Taiwanese women. Clin Chem Lab Med 45:1219-1223.
6. Calabresi L, Rossoni G, Gomaraschi M, Sisto F, Berti F, Franceschini G. (2003). High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-a content and enhancing prostaglandin release. Circ Res 92:330-337.
7. Chertov O, Biragyn A, Kwak LW, Simpson JT, Boronina T, Hoang VM, Prieto DA, Conrads TP, Veenstra TD, Fisher RJ. (2004). Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry. Proteomics 4:1195-1203.
8. Ehmann M, Felix K, Hartmann D, Schnölzer M, Nees M, Vorderwülbecke S, Bogumil R, Büchler MW, Friess H. (2007). Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 34:205-214.
9. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592.
10. Flynn R, Qian K, Tang C, Dronadula N, Buckler JM, Jiang B, Wen S, Dichek HL, Dichek DA. (2011). Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis. Mol Ther 19:1833-1841.
11. Guzalnur A, Peng Z, Guo Y. (2004). Differential expression of HPV and its subtypes cervical cancer specimens in the Han nationality in Sichuan and Uyghur women in the Northwest Xinjiang. Chin J Microbiol Immunol 24:406.
12. Gupta S, Sodhani P. (2004). Why is high grade squamous intraepithelial neoplasia under-diagnosed on cytology in a quarter of cases? Analysis of smear characteristics in discrepant cases. Indian J Cancer 41:104-108.
13. Guo X, Abulizi A, Wu G, Liu K. (2009) Two-dimentional liquid phase chromatographic proteome profiles in Uygur women with uterine cervix cancer. J Cent South Univ (Med Sci) 34:624-629.
14. Han C, Zhang HT, Du L, Liu X, Jing J, Zhao X, Yang X, Tian B. (2005). Serum levels of leptin, insulin, and lipids in relation to breast cancer in China. Endocrine 26:19-24.
15. Jeong DH, Kim HK, Prince AE, Lee DS, Kim YN, Han J, Kim KT. (2008). Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix. J Gynecol Oncol 19:173-180.
16. Jayaraman S, Abe-Dohmae S, Yokoyama S, Cavigiolio G. (2011). Impact of self-association on function of apolipoprotein A-I. J Biol Chem 286:35610-35623.
17. Jacobs EJ, Gapstur SM. (2009). Cholesterol and cancer: answers and new questions. Cancer Epidemiol Biomarkers Prev 18:2805-2806.
18. Linkov F, Yurkovetsky Z, Lokshin A. (2007). Biomarker approaches to the development of cancer screening tests: can cancer blood tests become a routine health check-up? Future Oncol 3:295-298.
19. Looi ML, Karsani SA, Rahman MA, Dali AZ, Ali SA, Ngah WZ, Yusof YA. (2009). Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma. J Biosci 34:917-925.
20. Massad LS, Behbakht K, Collins YC, Cejtin HE. (2003). Histologic findings from the cervix among older women with abnormal cervical cytology. Gynecol Oncol 88:340-344.
21. Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, Steinhoff M, Messerlian G, DiSilvestro P, Granai CO, Bast RC Jr. (2008). The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 108:402-408.
22. Moore LE, Fung ET, McGuire M, Rabkin CC, Molinaro A, Wang Z, Zhang F, Wang J, Yip C, Meng XY, Pfeiffer RM. (2006). Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population. Canc Epidemiol Biomarkers Prev 15:1641-1646.
23. Muntoni S, Atzori L, Mereu R, Satta G, Macis MD, Congia M, Tedde A, Desogus A, Muntoni S. (2009). Serum lipoproteins and cancer. Nutr Metab Cardiovasc Dis 19:218-225.
24. Patterson SD. (2004). How much of the proteome do we see with discovery-based proteomics methods and how much do we need to see? Curr Proteomics 1:3-12.
25. Rappsilber J, Mann M. (2002). Is mass spectrometry ready for proteome-wide protein expression analysis? Genome Biol 3:COMMENT2008.
26. Suzuke L, Peng YH, Zhou K. (2006). The analysis of pathogenetic tendency of cervical cancer in various ethnic women in Xinjiang. J Xinjiang Med Univ 29:569-571.
27. Siddiqui NH. (2000).Tumors of the cervix. Arch Pathol Lab Med 124:1242.
28. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. (2001). Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93:1054-1061.
29. Simpson DC, Kabyemela E, Muehlenbachs A, Ogata Y, Mutabingwa TK, Duffy PE, Fried M. (2010). Plasma levels of apolipoprotein A1 in malaria-exposed primigravidae are associated with severe anemia. PLoS ONE 5:e8822.
30. Sheng S, Skalnikova H, Meng A, Tra J, Fu Q, Everett A, Van Eyk J. (2011). Intact protein separation by one- and two-dimensional liquid chromatography for the comparative proteomic separation of partitioned serum or plasma. Methods Mol Biol 728: 29-46.
31. Sihlbom C, Kanmert I, Bahr H, Davidsson P. (2008). Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins. J Proteome Res 7:4191-4198.
32. Ince U, Aydin O, Peker O. (2011). Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears. Gynecol Oncol 121:152-156.
33. Van Hemelrijck M, Walldius G, Jungner I, Hammar N, Garmo H, Binda E, Hayday A, Lambe M, Holmberg L. (2011). Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study. Canc Causes Contr 22:1011-1019.
34. William CS. (2007). Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6:25.
35. Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ. (2008). Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Nat Rev Drug Discov 7:84-99.
36. Wullschleger S, Loewith R, Hall MN. (2006). TOR signaling in growth and metabolism. Cell 124:471-484.
37. Xia T, Zheng ZG, Gao Y, Mou HZ, Xu SH, Zhang P, Zhu JQ. (2008). [Application of SELDI-TOF serum proteome profiling in cervical squamous cell carcinoma]. Ai Zheng 27: 279-282.
38. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF. (2004). Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 109: 418-424.
39. Yui Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C. (1988). Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I. J Clin Invest 82:803-807.
40. Yecies JL, Manning BD. (2011). mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med 89:221-228.
41. Yadav AK, Bhardwaj G, Basak T, Kumar D, Ahmad S, Priyadarshini R, Singh AK, Dash D, Sengupta S. (2011). A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery. PLoS ONE 6: e24442.
42. Zuna RE, Sienko A, Lightfoot S, Gaiser M. (2002). Cervical smear interpretations in women with a histologic diagnosis of severe dysplasia: factors associated with discrepant interpretations. Cancer 96:218-224.